With a focus on femtech, MedAnswers announced that it landed $5 million in seed funding. This news comes in conjunction with the rollout of its new tool FertilityAnswers, dedicated to providing information to users trying to get pregnant.
The Los Angeles- and Barcelona-based startup was backed by lead funder Special Situations’ Life Sciences Innovation (LSI) Fund with participation from Viking...
Old Saybrook, Connecticut-based Fertility Focus, maker of the OvuSense connected fertility tracking platform, has raised $2.7 million in a Series A round led by Foresight Group and Coutts Investment Club.
Further, the company announced a global partnership with Cambridge, UK-based digital sensor company Sensiia, which it said in a statement will lead to the development of “additional sensor...
The UK’s Advertising Standards Authority (ASA) has found a Facebook ad describing Natural Cycles as a "highly accurate contraceptive app" and a "clinically tested alternative to birth control methods" to be misleading after receiving three complaints about the paid-for post.
The Swedish company said it removed the ad, which ran for approximately four weeks in mid-2017, as soon as it was notified...
The FDA announced today that it will allow marketing of Natural Cycles’ contraception app in the US for pre-menopausal women aged 18 years and older. Previously approved in the UK and currently the subject of investigation by multiple regulatory agencies, the algorithm-driven app helps users track their menstrual cycle and informs them when they are most fertile.
“Consumers are increasingly using...
San Francisco-based OW Health, women's health-focused digital health company that makes digital health app Flo, has raised $1 million seed funding in a round led by Flint Capital and Haxus Venture Fund. The funding will allow the company to expand use of the app globally as well as the develop machine learning required for the app to evolve into a personal health and wellness assistant for women...
Fertility apps aren’t just for women. A new male fertility kit and companion app from Medical Electronic Systems, which makes commercial-grade automated semen analyzers, allows men to test their semen at home using their smartphone.
The test is called YO, and features a clip-on mini microscope that users attach to their smartphone, plus a sample collection cup, a testing slide, a plastic pipette...
New York City-based digital health company Progyny, which offers a number of fertility services including concierge services for in-vitro fertilization, egg freezing, adoption and fertility benefits, has rebranded its direct-to-consumer products under the parent company. Additionally, Progyny will also launch a new website and offer extra features for people navigating fertility services.
The...
The market for women-specific digital health tools is ripe, buttressed by the growing number of women tech entrepreneurs, the desire for family planning data, and increasing call for accommodations for women in the workplace, according to a panel at TechCrunch Disrupt in San Francisco. While women haven’t historically been the focus in technology – both in the workforce or in the consumer target...
Updated with a statement from Glow
Wired Magazine splashed some cold water on fertility app Glow's assertion that a new study shows their users have a 40 percent higher likelihood of getting pregnant than those who don't use the app.
The problem, the magazine asserted after speaking with multiple fertility scientists not associated with the company, is based on a classic scientific aphorism:...
Ovia Pregnancy
Boston-based women's health app developer Ovuline has raised $3.2 million from Martin Ventures and Zaffre Investments, the investment arm of Blue Cross Blue Shield of Massachusetts. About $1 million of this investment came from Zaffre Investments. This brings the company’s total funding to at least $5.7 million.
Ovuline offers two apps, Ovia Pregnancy and Ovia Fertility, which ...
